Killing of Plasmodium falciparum by eosinophil secretory products.
The multiplication of two strains of Plasmodium falciparum in culture, as measured by [3H]hypoxanthine incorporation, was inhibited in a dose-dependent manner by granule proteins secreted by purified eosinophils obtained from patients with the hypereosinophilic syndrome. Morphological examination revealed the presence of abnormal parasites inside erythrocytes, indicating that they were killed in situ, and the later stages of the developmental cycle were found to be most susceptible to these toxic effects. A monoclonal antibody against eosinophil cationic protein partially blocked the inhibitory effect, suggesting that it was caused by more than one of the eosinophil granule proteins. Thus some of the antimalarial effects of molecules such as the tumor necrosis factor, which activates eosinophils, may be mediated through the enhanced production of eosinophil secretion products.
D000911:Antibodies, Monoclonal; D001798:Blood Proteins / Q000502:physiology*; D003594:Cytoplasmic Granules / Q000502:physiology; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000276:immunology*; D004912:Erythrocytes / Q000469:parasitology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008288:Malaria / Q000276:immunology; D010963:Plasmodium falciparum / Q000254:growth & development / Q000276:immunology*; D012260:Ribonucleases
D000911:Antibodies, Monoclonal; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D012260:Ribonucleases